NIR Enhanced pH‐Responsive Microneedles for Synergetic Therapy of Melanoma
ChemMedChem · 2025
DOI: 10.1002/cmdc.202400537 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Weiqiang Han und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling, 712100, China. Hauptthemen laut MEDLINE: Melanoma, Doxorubicin, Infrared Rays, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Project of Science and Technology of Social Development in Shaanxi Province, GuangDong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Melanoma has emerged as a significant threat to human life and health. Microneedle (MN)‐mediated transdermal drug delivery (TDD) has garnered attention in melanoma treatment for bypassing the first‐pass effect. However, the propensity of melanoma to metastasize presents substantial challenges for MN mediated local treatment. Developing systemic therapies, such as immunotherapy in combination with TDD, is crucial for achieving effective melanoma treatment. Herein, a polyvinyl alcohol (PVA) MN‐mediated multifunctional TDD system, designated MN@PDA@1‐MT/CUR/DOX@HA (MN@PMCDH), was developed for synergetic chemotherapy/photothermal/immunotherapy of melanoma. PMCDH nanomedicines penetrate deep skin layers through MNs, accumulate at tumor sites guided by hyaluronic acid (HA), and selectively release drugs in response to the acidic tumor microenvironment and near‐infrared (NIR) stimulation. Released curcumin (CUR) significantly enhances the efficacy of photothermal therapy (PTT) and chemotherapy, as well as improves the induction of immunogenic cell death (ICD) by increasing melanoma sensitivity to polydopamine (PDA)‐mediated photothermal effects and doxorubicin (DOX). Moreover, the incorporation of 1‐methyltryptophan (1‐MT) to reverse the tumor immunosuppressive microenvironment can further enhance the effects of immunotherapy. In vitro studies revealed that the MN@PMCDH system can effectively induce ICD and inhibit tumor cell growth. Additionally, remarkable deep tumor cell inhibition effects are also achieved in 3D tumor models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling, 712100, China.
- State Key Laboratory of Fine Chemicals, School of Chemistry, Dalian University of Technology, No. 2 Linggong Road, Ganjingzi District, Dalian, 116023, PR China.
- Shenzhen Research Institute, Northwest A&F University, Shenzhen, 518000, China.
ORCID-Profile: Shiguo Sun
Förderung
- National Natural Science Foundation of China
- Project of Science and Technology of Social Development in Shaanxi Province
- GuangDong Basic and Applied Basic Research Foundation
- Qin Chuangyuan Traditional Chinese Medicine Innovation Research and Development Project
- Key R&D Projects of Ningxia Hui Nationality Autonomous Region in 2022
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Han, W., Yu, L., Liu, Z., Wang, C., Zhang, Q., Li, H., Xu, Y., Liu, F., & Sun, S. (2025). NIR Enhanced pH‐Responsive Microneedles for Synergetic Therapy of Melanoma. ChemMedChem. https://doi.org/10.1002/cmdc.202400537
Vancouver
Han W, Yu L, Liu Z, Wang C, Zhang Q, Li H, et al. NIR Enhanced pH‐Responsive Microneedles for Synergetic Therapy of Melanoma. ChemMedChem. 2025. doi:10.1002/cmdc.202400537
BibTeX
@article{Han2025,
author = {Han, Weiqiang and Yu, Lan and Liu, Zhuo and Wang, Chaofan and Zhang, Qi and Li, Hongjuan and Xu, Yongqian and Liu, Fengyu and Sun, Shiguo},
title = {NIR Enhanced pH‐Responsive Microneedles for Synergetic Therapy of Melanoma},
journal = {ChemMedChem},
year = {2025},
doi = {10.1002/cmdc.202400537}
}
EUVIMED